1.
Zijlstra JM, Burggraaff CN, Kersten MJ, Barrington SF. FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?. Haematologica [Internet]. 2016Oct.31 [cited 2026Nov.17];101(11):1279-83. Available from: https://haematologica.org/article/view/7871